Académique Documents
Professionnel Documents
Culture Documents
RESEARCH DESIGN
FLORELIZ V. NGAYA-AN, PHD, RN
RESEARCH DESIGNS
▸ NON EXPERIMENTAL
▸ EXPERIMENTAL
▸ QUASI-EXPERIEMENTAL
DESIGN ACCORDING TO PURPOSE
▸ exploratory
▸ descriptive
▸ explanatory
▸ evaluation
DESIGN ACCORDING TO TIME
DIMENSIONS
▸ cross-sectional (involve the collection of data at one
point in time)
▸ prospective
▸ retrospective
NON-
EXPERIMENTAL
DO BIRTH WEIGHTS UNDER
1,500 GRAMS CAUSE
DEVELOPMENTAL DELAYS IN
NON EXPERIMENTAL DESIGNS
▸ CORRELATIONAL
▸ PROSPECTIVE (COHORT)
▸ RETROSPECTIVE
▸ DESCRIPTIVE
▸ DESCRIPTIVE CORRELATIONAL
CORRELATIONAL
EXPERIMENTAL DESIGN
▸ researchers are active agents not passive observers
▸ controlled experiment is considered gold standard for
yielding reliable evidence about cause and effects
▸ alternative intervention
▸ placebo
▸ standard methods of care
▸ different doses or intensities of treatment
▸ wait list control group
▸ attention control group
TEXT
INTERNAL VALIDITY
▸ refers to the extent to which it is possible to make an
inference that the independent variable is truly causing or
influencing the dependent variable
EXTERNAL VALIDITY
▸ concerns inferences about the extent to which relationships
observed in a study hold true for different people, conditions,
and settings
THREATS TO INTERNAL VALIDITY
▸ history threat
some unanticipated event occurred while the experiment
was in progress and affected the dependent variable
▸ maturation threat
changes in the dependent variable due to normal
developmental processes operating within the subject as a
function of time
THREATS TO INTERNAL VALIDITY
▸ temporal ambiguity- a question of whether the independent
variable precedes the dependent variable
▸ selection threat
biases resulting from pre-existing differences between
groups
▸ mortality
Differential loss of participants across groups
TEXT
▸ Phase I - occurs after the initial development of the drug or therapy and is
designed primarily to establish safety and tolerance, and to determine optimal
dose or strength of the therapy.
▸ Phase II - involves seeking preliminary evidence of controlled effectiveness.